ID   ALG1_HUMAN              Reviewed;         464 AA.
AC   Q9BT22; B4DP08; Q6UVZ9; Q8N5Y4; Q9P2Y2;
DT   30-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 2.
DT   10-MAY-2017, entry version 149.
DE   RecName: Full=Chitobiosyldiphosphodolichol beta-mannosyltransferase;
DE            EC=2.4.1.142;
DE   AltName: Full=Asparagine-linked glycosylation protein 1 homolog;
DE   AltName: Full=Beta-1,4-mannosyltransferase;
DE   AltName: Full=GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase;
DE   AltName: Full=GDP-mannose-dolichol diphosphochitobiose mannosyltransferase;
DE   AltName: Full=Mannosyltransferase-1;
DE            Short=MT-1;
DE            Short=hMat-1;
GN   Name=ALG1; Synonyms=HMAT1, HMT1; ORFNames=PSEC0061, UNQ861/PRO1870;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND FUNCTION.
RC   TISSUE=Fetal brain;
RX   PubMed=10704531; DOI=10.1093/glycob/10.3.321;
RA   Takahashi T., Honda R., Nishikawa Y.;
RT   "Cloning of the human cDNA which can complement the defect of the
RT   yeast mannosyltransferase I-deficient mutant alg 1.";
RL   Glycobiology 10:321-327(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Teratocarcinoma;
RX   PubMed=16303743; DOI=10.1093/dnares/12.2.117;
RA   Otsuki T., Ota T., Nishikawa T., Hayashi K., Suzuki Y., Yamamoto J.,
RA   Wakamatsu A., Kimura K., Sakamoto K., Hatano N., Kawai Y., Ishii S.,
RA   Saito K., Kojima S., Sugiyama T., Ono T., Okano K., Yoshikawa Y.,
RA   Aotsuka S., Sasaki N., Hattori A., Okumura K., Nagai K., Sugano S.,
RA   Isogai T.;
RT   "Signal sequence and keyword trap in silico for selection of full-
RT   length human cDNAs encoding secretion or membrane proteins from oligo-
RT   capped cDNA libraries.";
RL   DNA Res. 12:117-126(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X.,
RA   Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A.,
RA   Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J.,
RA   Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L.,
RA   Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A.,
RA   Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D.,
RA   Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J.,
RA   Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M.,
RA   Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I.,
RA   Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W.,
RA   Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A.,
RA   Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S.,
RA   Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L.,
RA   Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A.,
RA   Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L.,
RA   Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N.,
RA   Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M.,
RA   Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L.,
RA   Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D.,
RA   Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P.,
RA   Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M.,
RA   Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANTS
RP   ASN-267; MET-325 AND ARG-455.
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 2-464 (ISOFORM 1).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S.,
RA   Huang A., Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J.,
RA   Lewis L., Liao D., Mark M.R., Robbie E., Sanchez C., Schoenfeld J.,
RA   Seshagiri S., Simmons L., Singh J., Smith V., Stinson J., Vagts A.,
RA   Vandlen R.L., Watanabe C., Wieand D., Woods K., Xie M.-H.,
RA   Yansura D.G., Yi S., Yu G., Yuan J., Zhang M., Zhang Z., Goddard A.D.,
RA   Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale
RT   effort to identify novel human secreted and transmembrane proteins: a
RT   bioinformatics assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [8]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-242, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   VARIANT CDG1K LEU-258.
RX   PubMed=14973778; DOI=10.1086/382492;
RA   Schwarz M., Thiel C., Luebbehusen J., Dorland B., de Koning T.,
RA   von Figura K., Lehle L., Koerner C.;
RT   "Deficiency of GDP-Man:GlcNAc2-PP-dolichol mannosyltransferase causes
RT   congenital disorder of glycosylation type Ik.";
RL   Am. J. Hum. Genet. 74:472-481(2004).
RN   [11]
RP   VARIANTS CDG1K LEU-258 AND PRO-342.
RX   PubMed=14973782; DOI=10.1086/382493;
RA   Kranz C., Denecke J., Lehle L., Sohlbach K., Jeske S., Meinhardt F.,
RA   Rossi R., Gudowius S., Marquardt T.;
RT   "Congenital disorder of glycosylation type Ik (CDG-Ik): a defect of
RT   mannosyltransferase I.";
RL   Am. J. Hum. Genet. 74:545-551(2004).
RN   [12]
RP   VARIANTS CDG1K ARG-150 AND LEU-258, AND VARIANT GLU-429.
RX   PubMed=14709599; DOI=10.1093/hmg/ddh050;
RA   Grubenmann C.E., Frank C.G., Huelsmeier A.J., Schollen E.,
RA   Matthijs G., Mayatepek E., Berger E.G., Aebi M., Hennet T.;
RT   "Deficiency of the first mannosylation step in the N-glycosylation
RT   pathway causes congenital disorder of glycosylation type Ik.";
RL   Hum. Mol. Genet. 13:535-542(2004).
RN   [13]
RP   INVOLVEMENT IN CDG1K, FUNCTION, VARIANTS CDG1K ARG-50; PHE-71; LEU-74;
RP   VAL-88; LEU-98; PHE-114; ARG-150; SER-209; LEU-258; TRP-276; PHE-281;
RP   GLY-289; VAL-291; ASP-353; ARG-358; LEU-359; VAL-360; ALA-363;
RP   GLN-366; GLN-367; LYS-382; ARG-384; SER-388 AND TRP-438,
RP   CHARACTERIZATION OF VARIANTS CDG1K ARG-50; PHE-71; LEU-74; VAL-88;
RP   LEU-98; PHE-114; ARG-150; SER-209; LEU-258; TRP-276; PHE-281; GLY-289;
RP   VAL-291; ASP-353; ARG-358; LEU-359; VAL-360; ALA-363; GLN-366;
RP   GLN-367; LYS-382; ARG-384; SER-388 AND TRP-438, AND CHARACTERIZATION
RP   OF VARIANT ASN-267.
RX   PubMed=26931382; DOI=10.1002/humu.22983;
RG   University of Washington Center for Mendelian Genomics;
RA   Ng B.G., Shiryaev S.A., Rymen D., Eklund E.A., Raymond K., Kircher M.,
RA   Abdenur J.E., Alehan F., Midro A.T., Bamshad M.J., Barone R.,
RA   Berry G.T., Brumbaugh J.E., Buckingham K.J., Clarkson K., Cole F.S.,
RA   O'Connor S., Cooper G.M., Van Coster R., Demmer L.A., Diogo L.,
RA   Fay A.J., Ficicioglu C., Fiumara A., Gahl W.A., Ganetzky R., Goel H.,
RA   Harshman L.A., He M., Jaeken J., James P.M., Katz D., Keldermans L.,
RA   Kibaek M., Kornberg A.J., Lachlan K., Lam C., Yaplito-Lee J.,
RA   Nickerson D.A., Peters H.L., Race V., Regal L., Rush J.S.,
RA   Rutledge S.L., Shendure J., Souche E., Sparks S.E., Trapane P.,
RA   Sanchez-Valle A., Vilain E., Voello A., Waechter C.J., Wang R.Y.,
RA   Wolfe L.A., Wong D.A., Wood T., Yang A.C., Matthijs G., Freeze H.H.;
RT   "ALG1-CDG: Clinical and Molecular Characterization of 39 Unreported
RT   Patients.";
RL   Hum. Mutat. 37:653-660(2016).
CC   -!- FUNCTION: Participates in the formation of the lipid-linked
CC       precursor oligosaccharide for N-glycosylation. Involved in
CC       assembling the dolichol-pyrophosphate-GlcNAc(2)-Man(5)
CC       intermediate on the cytoplasmic surface of the ER.
CC       {ECO:0000269|PubMed:10704531, ECO:0000269|PubMed:26931382}.
CC   -!- CATALYTIC ACTIVITY: GDP-mannose + chitobiosyldiphosphodolichol =
CC       GDP + beta-1,4-D-mannosylchitobiosyldiphosphodolichol.
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000305}; Single-pass type II membrane protein {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9BT22-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9BT22-2; Sequence=VSP_056931;
CC         Note=No experimental confirmation available.;
CC   -!- DISEASE: Congenital disorder of glycosylation 1K (CDG1K)
CC       [MIM:608540]: A form of congenital disorder of glycosylation, a
CC       multisystem disorder caused by a defect in glycoprotein
CC       biosynthesis and characterized by under-glycosylated serum
CC       glycoproteins. Congenital disorders of glycosylation result in a
CC       wide variety of clinical features, such as defects in the nervous
CC       system development, psychomotor retardation, dysmorphic features,
CC       hypotonia, coagulation disorders, and immunodeficiency. The broad
CC       spectrum of features reflects the critical role of N-glycoproteins
CC       during embryonic development, differentiation, and maintenance of
CC       cell functions. {ECO:0000269|PubMed:14709599,
CC       ECO:0000269|PubMed:14973778, ECO:0000269|PubMed:14973782,
CC       ECO:0000269|PubMed:26931382}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase group 1 family.
CC       Glycosyltransferase 33 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAQ89432.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB019038; BAA90748.1; -; mRNA.
DR   EMBL; AK298144; BAG60420.1; -; mRNA.
DR   EMBL; AK075373; BAC11576.1; -; mRNA.
DR   EMBL; AC026458; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC004402; AAH04402.1; -; mRNA.
DR   EMBL; BC031095; AAH31095.1; -; mRNA.
DR   EMBL; AY359073; AAQ89432.1; ALT_INIT; mRNA.
DR   CCDS; CCDS10528.1; -. [Q9BT22-1]
DR   CCDS; CCDS81946.1; -. [Q9BT22-2]
DR   RefSeq; NP_001317433.1; NM_001330504.1. [Q9BT22-2]
DR   RefSeq; NP_061982.3; NM_019109.4. [Q9BT22-1]
DR   RefSeq; XP_016878947.1; XM_017023458.1. [Q9BT22-2]
DR   UniGene; Hs.592086; -.
DR   ProteinModelPortal; Q9BT22; -.
DR   BioGrid; 121033; 6.
DR   IntAct; Q9BT22; 6.
DR   STRING; 9606.ENSP00000262374; -.
DR   CAZy; GT33; Glycosyltransferase Family 33.
DR   iPTMnet; Q9BT22; -.
DR   PhosphoSitePlus; Q9BT22; -.
DR   SwissPalm; Q9BT22; -.
DR   BioMuta; ALG1; -.
DR   DMDM; 73921663; -.
DR   EPD; Q9BT22; -.
DR   MaxQB; Q9BT22; -.
DR   PaxDb; Q9BT22; -.
DR   PeptideAtlas; Q9BT22; -.
DR   PRIDE; Q9BT22; -.
DR   DNASU; 56052; -.
DR   Ensembl; ENST00000262374; ENSP00000262374; ENSG00000033011. [Q9BT22-1]
DR   Ensembl; ENST00000544428; ENSP00000440019; ENSG00000033011. [Q9BT22-2]
DR   Ensembl; ENST00000588623; ENSP00000468118; ENSG00000033011. [Q9BT22-2]
DR   GeneID; 56052; -.
DR   KEGG; hsa:56052; -.
DR   UCSC; uc002cyj.4; human. [Q9BT22-1]
DR   CTD; 56052; -.
DR   DisGeNET; 56052; -.
DR   GeneCards; ALG1; -.
DR   H-InvDB; HIX0009871; -.
DR   H-InvDB; HIX0009901; -.
DR   H-InvDB; HIX0021452; -.
DR   H-InvDB; HIX0030817; -.
DR   H-InvDB; HIX0030848; -.
DR   H-InvDB; HIX0031467; -.
DR   H-InvDB; HIX0036459; -.
DR   HGNC; HGNC:18294; ALG1.
DR   HPA; HPA060392; -.
DR   MalaCards; ALG1; -.
DR   MIM; 605907; gene.
DR   MIM; 608540; phenotype.
DR   neXtProt; NX_Q9BT22; -.
DR   OpenTargets; ENSG00000033011; -.
DR   Orphanet; 79327; ALG1-CDG.
DR   PharmGKB; PA134979319; -.
DR   eggNOG; KOG2941; Eukaryota.
DR   eggNOG; COG0438; LUCA.
DR   GeneTree; ENSGT00390000008647; -.
DR   HOGENOM; HOG000216716; -.
DR   HOVERGEN; HBG055036; -.
DR   InParanoid; Q9BT22; -.
DR   KO; K03842; -.
DR   OMA; PKKRNAC; -.
DR   OrthoDB; EOG091G083J; -.
DR   PhylomeDB; Q9BT22; -.
DR   TreeFam; TF314121; -.
DR   BRENDA; 2.4.1.142; 2681.
DR   Reactome; R-HSA-446193; Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein.
DR   UniPathway; UPA00378; -.
DR   GeneWiki; ALG1; -.
DR   GenomeRNAi; 56052; -.
DR   PRO; PR:Q9BT22; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000033011; -.
DR   CleanEx; HS_ALG1; -.
DR   ExpressionAtlas; Q9BT22; baseline and differential.
DR   Genevisible; Q9BT22; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:Reactome.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0004578; F:chitobiosyldiphosphodolichol beta-mannosyltransferase activity; TAS:Reactome.
DR   GO; GO:0000030; F:mannosyltransferase activity; TAS:ProtInc.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; TAS:Reactome.
DR   GO; GO:0006486; P:protein glycosylation; IDA:UniProtKB.
DR   InterPro; IPR026051; ALG1-like.
DR   InterPro; IPR001296; Glyco_trans_1.
DR   PANTHER; PTHR13036; PTHR13036; 1.
DR   Pfam; PF00534; Glycos_transf_1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome;
KW   Congenital disorder of glycosylation; Disease mutation;
KW   Endoplasmic reticulum; Glycosyltransferase; Membrane; Phosphoprotein;
KW   Polymorphism; Reference proteome; Signal-anchor; Transferase;
KW   Transmembrane; Transmembrane helix.
FT   CHAIN         1    464       Chitobiosyldiphosphodolichol beta-
FT                                mannosyltransferase.
FT                                /FTId=PRO_0000080249.
FT   TOPO_DOM      1      2       Cytoplasmic. {ECO:0000255}.
FT   TRANSMEM      3     23       Helical; Signal-anchor for type II
FT                                membrane protein. {ECO:0000255}.
FT   TOPO_DOM     24    464       Lumenal. {ECO:0000255}.
FT   MOD_RES     242    242       Phosphoserine.
FT                                {ECO:0000244|PubMed:18691976,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ       1    111       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_056931.
FT   VARIANT      50     50       Q -> R (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs794726944).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077187.
FT   VARIANT      71     71       S -> F (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs200605408).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077188.
FT   VARIANT      74     74       H -> L (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs201337379).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077189.
FT   VARIANT      88     88       L -> V (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs794727301).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077190.
FT   VARIANT      98     98       P -> L (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077191.
FT   VARIANT     114    114       L -> F (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077192.
FT   VARIANT     150    150       S -> R (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs121908340).
FT                                {ECO:0000269|PubMed:14709599,
FT                                ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_023364.
FT   VARIANT     209    209       I -> S (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077193.
FT   VARIANT     258    258       S -> L (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs28939378).
FT                                {ECO:0000269|PubMed:14709599,
FT                                ECO:0000269|PubMed:14973778,
FT                                ECO:0000269|PubMed:14973782,
FT                                ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_023365.
FT   VARIANT     267    267       S -> N (polymorphism; no effect on
FT                                function in protein glycosylation;
FT                                dbSNP:rs17849848).
FT                                {ECO:0000269|PubMed:15489334,
FT                                ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_038425.
FT   VARIANT     276    276       R -> W (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs151173406).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077194.
FT   VARIANT     281    281       V -> F (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077195.
FT   VARIANT     289    289       D -> G (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077196.
FT   VARIANT     291    291       D -> V (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077197.
FT   VARIANT     325    325       L -> M (in dbSNP:rs17852920).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038426.
FT   VARIANT     342    342       Q -> P (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs267606651).
FT                                {ECO:0000269|PubMed:14973782}.
FT                                /FTId=VAR_023366.
FT   VARIANT     353    353       Y -> D (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077198.
FT   VARIANT     358    358       G -> R (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077199.
FT   VARIANT     359    359       S -> L (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077200.
FT   VARIANT     360    360       A -> V (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs398124348).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077201.
FT   VARIANT     363    363       G -> A (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077202.
FT   VARIANT     366    366       L -> Q (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077203.
FT   VARIANT     367    367       H -> Q (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077204.
FT   VARIANT     382    382       M -> K (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077205.
FT   VARIANT     384    384       G -> R (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast
FT                                strain). {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077206.
FT   VARIANT     388    388       P -> S (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs398124349).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_077207.
FT   VARIANT     429    429       D -> E (polymorphism; no effect on
FT                                function in protein glycosylation as
FT                                shown by rescue assays in an ALG1-
FT                                deficient yeast strain; dbSNP:rs9745522).
FT                                {ECO:0000269|PubMed:14709599}.
FT                                /FTId=VAR_023367.
FT   VARIANT     438    438       R -> W (in CDG1K; decreased function in
FT                                protein glycosylation as shown by rescue
FT                                assays in an ALG1-deficient yeast strain;
FT                                dbSNP:rs16835020).
FT                                {ECO:0000269|PubMed:26931382}.
FT                                /FTId=VAR_049350.
FT   VARIANT     455    455       Q -> R (in dbSNP:rs17856919).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_038427.
SQ   SEQUENCE   464 AA;  52518 MW;  83F55FD12CFDDBE9 CRC64;
     MAASCLVLLA LCLLLPLLLL GGWKRWRRGR AARHVVAVVL GDVGRSPRMQ YHALSLAMHG
     FSVTLLGFCN SKPHDELLQN NRIQIVGLTE LQSLAVGPRV FQYGVKVVLQ AMYLLWKLMW
     REPGAYIFLQ NPPGLPSIAV CWFVGCLCGS KLVIDWHNYG YSIMGLVHGP NHPLVLLAKW
     YEKFFGRLSH LNLCVTNAMR EDLADNWHIR AVTVYDKPAS FFKETPLDLQ HRLFMKLGSM
     HSPFRARSEP EDPVTERSAF TERDAGSGLV TRLRERPALL VSSTSWTEDE DFSILLAALE
     KFEQLTLDGH NLPSLVCVIT GKGPLREYYS RLIHQKHFQH IQVCTPWLEA EDYPLLLGSA
     DLGVCLHTSS SGLDLPMKVV DMFGCCLPVC AVNFKCLHEL VKHEENGLVF EDSEELAAQL
     QMLFSNFPDP AGKLNQFRKN LRESQQLRWD ESWVQTVLPL VMDT
//
